US Stock MarketDetailed Quotes

Psyence Biomedical (PBM)

Watchlist
  • 0.7603
  • -0.1105-12.69%
Close Jan 22 15:59 ET
  • 0.6833
  • -0.0770-10.13%
Pre 05:50 ET
4.86MMarket Cap-0.36P/E (TTM)

Psyence Biomedical (PBM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2025
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-26.78%-3.73M
-85.00%-2.95M
-14.01%-1.59M
-1.4M
Net income from continuing operations
101.98%1.01M
-1,495.53%-51.16M
-72.55%-3.21M
---1.86M
Operating gains losses
-1,927.92%-519.31K
133.62%28.41K
---84.5K
----
Depreciation and amortization
1,678.33%4.27K
--240
--0
----
Other non cash items
-99.50%218.41K
--43.58M
----
----
Change In working capital
67.07%-386.2K
-179.39%-1.17M
1,038.80%1.48M
--129.74K
-Change in receivables
-188.83%-95.6K
197.96%107.62K
-209.80%-109.86K
--100.05K
-Change in prepaid assets
128.70%70.33K
-241.97%-245.08K
-56,019.30%-71.67K
--128.1579
-Change in payables and accrued expense
65.14%-360.93K
-162.41%-1.04M
5,511.67%1.66M
--29.56K
Cash from discontinued investing activities
Operating cash flow
-26.78%-3.73M
-85.00%-2.95M
-14.01%-1.59M
---1.4M
Investing cash flow
Cash flow from continuing investing activities
-183.39%-16.23K
-5.73K
0
-32.04K
Net PPE purchase and sale
-72.46%-9.88K
---5.73K
--0
----
Net other investing changes
---6.35K
----
----
---32.04K
Cash from discontinued investing activities
Investing cash flow
-183.39%-16.23K
---5.73K
--0
---32.04K
Financing cash flow
Cash flow from continuing financing activities
289.47%9.15M
100.35%2.35M
172.07%1.17M
-1.63M
Net issuance payments of debt
215.34%7.41M
--2.35M
--0
----
Net common stock issuance
--1.74M
--0
--0
----
Net other financing activities
----
----
172.07%1.17M
---1.63M
Cash from discontinued financing activities
Financing cash flow
289.47%9.15M
100.35%2.35M
172.07%1.17M
---1.63M
Net cash flow
Beginning cash position
-45.05%733.19K
-23.90%1.33M
-63.55%1.75M
--4.81M
Current changes in cash
998.69%5.4M
-43.40%-601.09K
86.28%-419.16K
---3.06M
End cash Position
736.78%6.14M
-45.05%733.19K
-23.97%1.33M
--1.76M
Free cash flow
-26.87%-3.74M
-85.36%-2.95M
-14.01%-1.59M
---1.4M
Currency Unit
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
--
--
(FY)Mar 31, 2025(FY)Mar 31, 2024(FY)Mar 31, 2023(FY)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -26.78%-3.73M-85.00%-2.95M-14.01%-1.59M-1.4M
Net income from continuing operations 101.98%1.01M-1,495.53%-51.16M-72.55%-3.21M---1.86M
Operating gains losses -1,927.92%-519.31K133.62%28.41K---84.5K----
Depreciation and amortization 1,678.33%4.27K--240--0----
Other non cash items -99.50%218.41K--43.58M--------
Change In working capital 67.07%-386.2K-179.39%-1.17M1,038.80%1.48M--129.74K
-Change in receivables -188.83%-95.6K197.96%107.62K-209.80%-109.86K--100.05K
-Change in prepaid assets 128.70%70.33K-241.97%-245.08K-56,019.30%-71.67K--128.1579
-Change in payables and accrued expense 65.14%-360.93K-162.41%-1.04M5,511.67%1.66M--29.56K
Cash from discontinued investing activities
Operating cash flow -26.78%-3.73M-85.00%-2.95M-14.01%-1.59M---1.4M
Investing cash flow
Cash flow from continuing investing activities -183.39%-16.23K-5.73K0-32.04K
Net PPE purchase and sale -72.46%-9.88K---5.73K--0----
Net other investing changes ---6.35K-----------32.04K
Cash from discontinued investing activities
Investing cash flow -183.39%-16.23K---5.73K--0---32.04K
Financing cash flow
Cash flow from continuing financing activities 289.47%9.15M100.35%2.35M172.07%1.17M-1.63M
Net issuance payments of debt 215.34%7.41M--2.35M--0----
Net common stock issuance --1.74M--0--0----
Net other financing activities --------172.07%1.17M---1.63M
Cash from discontinued financing activities
Financing cash flow 289.47%9.15M100.35%2.35M172.07%1.17M---1.63M
Net cash flow
Beginning cash position -45.05%733.19K-23.90%1.33M-63.55%1.75M--4.81M
Current changes in cash 998.69%5.4M-43.40%-601.09K86.28%-419.16K---3.06M
End cash Position 736.78%6.14M-45.05%733.19K-23.97%1.33M--1.76M
Free cash flow -26.87%-3.74M-85.36%-2.95M-14.01%-1.59M---1.4M
Currency Unit USDUSDUSDUSD
Audit Opinions Unqualified OpinionUnqualified Opinion with Explanatory Notes----
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More